MétaCan
Menu
Back to cohort
Record W2806075246

ThromboLUX - The First Routine Platelet Transfusion Quality Test

2010· article· en· W2806075246 on OpenAlexaff
Elisabeth Maurer‐Spurej, Gyasi Bourne, Paul Geyer, Paul Charlebois, Gene Wey, K. J. McCallum

Bibliographic record

VenueCMBES Proceedings · 2010
Typearticle
Languageen
FieldMedicine
TopicVenous Thromboembolism Diagnosis and Management
Canadian institutionsCanadian Blood ServicesUniversity of British Columbia
Fundersnot available
KeywordsMedicinePlatelet transfusionQuality (philosophy)PlateletPurchasingIntensive care medicineTransfusion medicineMedical emergencyOperations managementSurgeryEmergency medicineBlood transfusionInternal medicineEngineering
DOInot available

Abstract

fetched live from OpenAlex

Prior to the ThromboLUX, no single in vitro test existed that could be used individually to evaluate the quality and effectiveness of platelet concentrates for transfusion. As hospitals cannot currently predict effective from ineffective transfusions prior to seeing patient responses, they purchase all platelet products. In North America every year over 3 million platelet transfusions are given to heart surgery, bleeding or cancer patients at a cost of at least 1.5 billion dollars. LightIntegra intends to make platelet quality testing a regular practice in blood banks around the world by making it accessible, affordable, reliable and fast. The ThromboLUX uses the principle of dynamic light scattering (DLS) to determine the kind of particles in the platelet concentrate, how many of the particles exist, and how they respond to temperature stress. The temperature response of platelets was a breakthrough discovery and combined with state-of-the-art laser and optics technology the ThromboLUX addresses the market need to provide a safe, quick and simple diagnostic test for platelet quality and function. Provision of the ThromboLUX results prior to transfusion, will allow hospitals to reduce costs. As fewer ineffective transfusions will occur, and thus fewer repeat transfusions, hospitals will reduce platelet costs as they will only be purchasing ‘good’ platelet concentrates. Additionally, patient care will improve as physicians will no longer have the uncertainty of unsatisfactory transfusion outcome and patients will no longer be exposed to a huge, under-recognized risk. Patient costs will also decrease due to the reduction in the length of hospital stays. The significant cost reduction gained by eliminating the use of ineffective platelets, improved efficiency, and the correlation of the ThromboLUX test results with transfusion outcome are strong incentives for the adoption of ThromboLUX.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.216
Threshold uncertainty score0.568

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.016
GPT teacher head0.281
Teacher spread0.265 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2010
Admission routes1
Has abstractyes

Explore more

Same venueCMBES ProceedingsSame topicVenous Thromboembolism Diagnosis and ManagementFrench-language works237,207